BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/20/2016 5:04:00 PM | Browse: 1081 | Download: 1346
Publication Name World Journal of Gastroenterology
Manuscript ID 21905
Country/Territory Canada
Received
2015-07-31 09:51
Peer-Review Started
2015-07-31 11:50
To Make the First Decision
2015-08-31 08:31
Return for Revision
2015-09-06 16:38
Revised
2015-09-20 02:53
Second Decision
2015-11-11 16:57
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2015-11-24 16:53
Articles in Press
2015-11-24 16:53
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-12-29 10:26
Publish the Manuscript Online
2016-01-20 16:55
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Transplantation
Manuscript Type Review
Article Title Hepatitis C in non-hepatic solid organ transplant candidates and recipients: A new horizon
Manuscript Source Invited Manuscript
All Author List Sara Belga and Karen Elizabeth Doucette
Funding Agency and Grant Number
Corresponding Author Karen Elizabeth Doucette, MD, MSc, Division of Infectious Diseases, Department of Medicine, University of Alberta, 11350 83 Avenue, Clinical Sciences Building 1-139, Edmonton, Alberta T6G 2G3, Canada. karen.doucette@ualberta.ca
Key Words Hepatitis C; chronic; Kidney transplantation; Heart transplantation; Lung transplantation; Liver trans­plantation; Kidney failure; Chronic; Antiviral agents
Core Tip Direct acting antiviral (DAA) therapy has the potential to eliminate hepatitis C virus (HCV) from the population of organ transplant candidates and recipients and thereby the negative impact of HCV on outcomes. Among non-hepatic organ transplant patients, the biggest barriers currently are limited safety and efficacy data in this population, particularly in those with advanced renal disease, and global variability of access and reimbursement for DAAs. Future research is needed to better assess safety, efficacy and impact of DAA therapy in non-hepatic solid organ transplant, as well as to explore the safety of using HCV infected donors, with prophylactic therapy, to expand the donor pool.
Publish Date 2016-01-20 16:55
Citation Belga S, Doucette KE. Hepatitis C in non-hepatic solid organ transplant candidates and recipients: A new horizon. World J Gastroenterol 2016; 22(4): 1650-1663
URL http://www.wjgnet.com/1007-9327/full/v22/i4/1650.htm
DOI http://dx.doi.org/10.3748/wjg.v22.i4.1650
Full Article (PDF) WJG-22-1650.pdf
Full Article (Word) WJG-22-1650.doc
Manuscript File 21905-Review.docx
Answering Reviewers 21905-Answering reviewers.pdf
Audio Core Tip 21905-Audio core tip.wav
Conflict-of-Interest Disclosure Form 21905-Conflict of interest statement.pdf
Copyright License Agreement 21905-Copyright assignment.pdf
Peer-review Report 21905-Peer-review(s).pdf
Scientific Misconduct Check 21905-Scientific misconduct check.pdf
Scientific Editor Work List 21905-Scientific editor work list.pdf